- Home
- TLSI vs MCN Comparison
TLSI vs MCN Comparison
Compare TLSI & MCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSI
- MCN
- Stock Information
- Founded
- TLSI 2010
- MCN 2004
- Country
- TLSI United States
- MCN Canada
- Employees
- TLSI N/A
- MCN N/A
- Industry
- TLSI Medical Specialities
- MCN
- Sector
- TLSI Health Care
- MCN
- Exchange
- TLSI Nasdaq
- MCN Nasdaq
- Market Cap
- TLSI 150.0M
- MCN 127.3M
- IPO Year
- TLSI N/A
- MCN N/A
- Fundamental
- Price
- TLSI $5.05
- MCN $6.27
- Analyst Decision
- TLSI Strong Buy
- MCN
- Analyst Count
- TLSI 5
- MCN 0
- Target Price
- TLSI $10.90
- MCN N/A
- AVG Volume (30 Days)
- TLSI 112.5K
- MCN 52.9K
- Earning Date
- TLSI 08-12-2025
- MCN 01-01-0001
- Dividend Yield
- TLSI N/A
- MCN 9.96%
- EPS Growth
- TLSI N/A
- MCN N/A
- EPS
- TLSI N/A
- MCN N/A
- Revenue
- TLSI $35,990,000.00
- MCN N/A
- Revenue This Year
- TLSI $56.79
- MCN N/A
- Revenue Next Year
- TLSI $54.15
- MCN N/A
- P/E Ratio
- TLSI N/A
- MCN N/A
- Revenue Growth
- TLSI 45.50
- MCN N/A
- 52 Week Low
- TLSI $3.42
- MCN $6.69
- 52 Week High
- TLSI $5.88
- MCN $8.60
- Technical
- Relative Strength Index (RSI)
- TLSI 55.11
- MCN 52.36
- Support Level
- TLSI $4.80
- MCN $6.26
- Resistance Level
- TLSI $5.24
- MCN $6.31
- Average True Range (ATR)
- TLSI 0.35
- MCN 0.05
- MACD
- TLSI 0.02
- MCN 0.00
- Stochastic Oscillator
- TLSI 72.18
- MCN 64.65
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About MCN Madison Covered Call & Equity Strategy Fund
XAI Madison Equity Premium Income Fund is an investment management company. The Fund invests in an actively managed equity portfolio comprised of individual stocks and covered call options. The Fund's primary investment objective is to provide high level of current income and gains, with a secondary objective of capital appreciation.